Senate Republicans led by Majority Leader Mitch McConnell (Ky.) unveiled the discussion draft of their own bill Thursday to replace the Affordable Care Act (ACA), popularly known as Obamacare, which overhauled and expanded health insurance coverage for millions of Americans.

June 22, 2017 — The U.S. Food and Drug Administration (FDA) has identified Vascular Solutions’ recent recall of its Venture catheters as a Class I recall, it announced this week. This is the most serious type of recall, because the FDA said use of these devices may cause serious injuries or death.

Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European Heart Rhythm Association (EHRA) EUROPACE - CARDIOSTIM 2017 conference, June 18-21 in Vienna, Austria. Devices revealed the time and cause of death in some cases where autopsy failed to do so.

BioTrace Medical Inc. announced that the company’s Tempo Temporary Pacing Lead was featured in an oral presentation and two live cases during the Transcatheter Valve Therapies (TVT) 2017 conference, June 14-17 in Chicago. Tamim Nazif, M.D., director of clinical services of the Structural Heart and Valve Center at NewYork-Presbyterian/Columbia University Medical Center, presented real-world experiences with the Tempo Lead from transcatheter aortic valve replacement (TAVR) cases.

Mount Sinai Heart and BioImage-2 LLC recently announced the start of the BioImage-2 study investigating the progression of vascular atherosclerotic plaque in patients who previously participated in the BioImage study.

I saw several elements of what will likely make up the next generation of echocardiography imaging systems at the the American Society of Echocardiography (ASE) 2017 scientific sessions in June. I have seen or heard of these technologies for the past few years, but for the first time I saw them all moving forward and starting to coalesce into real, tangible products. 

June 20, 2017 — Dutch medical device company Stroke2prevent BV recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for A-View, a medical device used in cardiac interventions. The A-View balloon catheter visualizes the aortic arch with transesophageal echocardiography (TEE).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now